Medical Director
Fulcrum Therapeutics
Cambridge, Massachusetts, United States
William Engelman, MD; Medical Director Fulcrum Therapeutics.
Fulcrum Therapeutics, Cambridge, MA December 2021 – present
Akcea Therapeutics, Boston, MA August 2020 – December 2021
Alnylam Pharmaceuticals, Cambridge, MA 2018 – 2020
Shire Pharmaceuticals, Cambridge, MA 2017 – 2018
Sunovion Pharmaceuticals, Inc., Marlborough, MA 2016 – 2017
ARIAD Pharmaceuticals, Inc., Cambridge, MA 2015 - 2016
Evidera/United BioSource Corp., Lexington, MA 2009 – 2015
University of Massachusetts Medical School, Pediatrics. Worcester, MA 2006 – 2008
DOCTOR OF MEDICINE ▪ Temple University – School of Medicine ▪ Philadelphia, PA: 2006
Disclosure information not submitted.
Interim Results of a Phase 1b study (PIONEER) of an oral HbF Inducer, pociredir, in SCD
Sunday, June 9, 2024
1:15 PM – 1:33 PM ET